News headlines about Castlight Health (NYSE:CSLT) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Castlight Health earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned news coverage about the software maker an impact score of 46.7357216044541 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the news articles that may have impacted Accern’s scoring:
- Health tech CEO who counts Amazon as a customer warns Jeff Bezos that it's a 'tough business' (finance.yahoo.com)
- Castlight Health Inc (CSLT) Expected to Post Quarterly Sales of $36.20 Million (americanbankingnews.com)
- Zacks: Analysts Expect Castlight Health Inc (CSLT) to Announce -$0.04 Earnings Per Share (americanbankingnews.com)
- Castlight Health (CSLT) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com)
- Castlight Health (CSLT) Rating Increased to Buy at Zacks Investment Research (americanbankingnews.com)
Shares of Castlight Health (CSLT) traded up $0.02 during trading hours on Tuesday, hitting $3.42. 49,857 shares of the company were exchanged, compared to its average volume of 342,973. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.03. Castlight Health has a twelve month low of $3.05 and a twelve month high of $4.75. The company has a market cap of $488.14, a P/E ratio of -7.23 and a beta of 1.57.
Several equities research analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Castlight Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 1st. Cantor Fitzgerald raised shares of Castlight Health from a “neutral” rating to an “overweight” rating and set a $5.00 target price for the company in a research report on Tuesday, January 30th. BidaskClub downgraded shares of Castlight Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, November 9th. Canaccord Genuity reissued a “buy” rating and issued a $7.00 target price on shares of Castlight Health in a research report on Thursday, October 26th. Finally, Chardan Capital lowered their price objective on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating for the company in a research report on Thursday, October 26th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $5.11.
In other Castlight Health news, CEO John C. Doyle sold 13,686 shares of the business’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.71, for a total transaction of $50,775.06. Following the completion of the transaction, the chief executive officer now directly owns 123,705 shares of the company’s stock, valued at approximately $458,945.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Mangini Siobhan Nolan sold 8,866 shares of the business’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.70, for a total transaction of $32,804.20. Following the transaction, the chief financial officer now directly owns 78,561 shares of the company’s stock, valued at $290,675.70. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 22,778 shares of company stock valued at $84,411. Insiders own 24.38% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was posted by Stock Observer and is the property of of Stock Observer. If you are accessing this news story on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this news story can be accessed at https://www.thestockobserver.com/2018/02/06/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-castlight-health-cslt-share-price.html.
Castlight Health Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.